$SKYH
Sky Harbour Group Corp

2021 Q2 Form 10-Q Financial Statement

#000143774921018940 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q2
Revenue $394.0K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $301.9K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $300.0K
YoY Change
% of Gross Profit
Operating Expenses $2.790M
YoY Change
Operating Profit $1.586M
YoY Change
Interest Expense $382.0K
YoY Change
% of Operating Profit 24.09%
Other Income/Expense, Net -$382.0K
YoY Change
Pretax Income $1.587M
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$2.778M
YoY Change
Net Earnings / Revenue -705.08%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 0.000
Diluted Shares Outstanding 0.000

Balance Sheet

Concept 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.5M
YoY Change
Cash & Equivalents $20.58M
Short-Term Investments $138.7M
Other Short-Term Assets $322.2K
YoY Change
Inventory
Prepaid Expenses $322.2K
Receivables
Other Receivables
Total Short-Term Assets $139.8M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $139.8M
Total Long-Term Assets $3.00
Total Assets $139.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $212.9K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.972M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $11.47M
YoY Change
Total Long-Term Liabilities $11.47M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.972M
Total Long-Term Liabilities $11.47M
Total Liabilities $16.44M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$15.37M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.37M
YoY Change
Total Liabilities & Shareholders Equity $139.8M
YoY Change

Cashflow Statement

Concept 2021 Q2
OPERATING ACTIVITIES
Net Income -$2.778M
YoY Change
Depreciation, Depletion And Amortization $300.0K
YoY Change
Cash From Operating Activities -$143.1K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $1.670M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $4.100K
YoY Change
Cash From Investing Activities $4.100K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K
YoY Change
NET CHANGE
Cash From Operating Activities -143.1K
Cash From Investing Activities 4.100K
Cash From Financing Activities 30.00K
Net Change In Cash -139.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$143.1K
Capital Expenditures $1.670M
Free Cash Flow -$1.813M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Liabilities
Liabilities
22917384 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18003841 USD
CY2021Q2 us-gaap Liabilities
Liabilities
16442657 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q2 ysac Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1 pure
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Cash
Cash
736005 USD
CY2020Q4 us-gaap Cash
Cash
1122194 USD
CY2021Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138725782 USD
CY2020Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138716226 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
322226 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
403186 USD
CY2021Q2 us-gaap Assets
Assets
139784013 USD
CY2020Q4 us-gaap Assets
Assets
140241606 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
212852 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153928 USD
CY2021Q2 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615 USD
CY2020Q4 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4972467 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4913543 USD
CY2021Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11470190 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15367744 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21384878 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-15367404 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21384538 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139784013 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140241606 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
149670 USD
us-gaap Professional Fees
ProfessionalFees
250904 USD
CY2021Q2 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
78197 USD
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
128197 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74054 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
147623 USD
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1887500 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6533651 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1585579 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6006927 USD
CY2021Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2074 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
13887 USD
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-732 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-3680 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1586921 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6017134 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
624276797 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13236 USD
ysac Maximum Dissolution Expenses Failure To Complete Business Combination
MaximumDissolutionExpensesFailureToCompleteBusinessCombination
100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1586921 USD
us-gaap Net Income Loss
NetIncomeLoss
6017134 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21384538 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4430213 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-16954325 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1586921 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-15367404 USD
us-gaap Net Income Loss
NetIncomeLoss
6017134 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-3680 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6533651 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-80960 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
58924 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-372953 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
624263561 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-386189 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1122194 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
736005 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q4 ysac Equity Issued During Period Price Per Unit
EquityIssuedDuringPeriodPricePerUnit
10.20
CY2021Q2 ysac Business Combination Required Fair Market Value Percentage Of Net Assets Held In Trust Account
BusinessCombinationRequiredFairMarketValuePercentageOfNetAssetsHeldInTrustAccount
0.80 pure
CY2021Q2 ysac Business Combination Minimum Percentage Of Voting Interest Acquired
BusinessCombinationMinimumPercentageOfVotingInterestAcquired
0.50 pure
CY2021Q2 ysac Business Combination Required Net Tangible Assets
BusinessCombinationRequiredNetTangibleAssets
5000001 USD
CY2021Q2 ysac Stock Redeemed Maximum Percentage Of Outstanding Shares
StockRedeemedMaximumPercentageOfOutstandingShares
0.15 pure
CY2021Q2 ysac Percentage Of Shares Mandatorily Redeemed If Fail To Complete Business Combination
PercentageOfSharesMandatorilyRedeemedIfFailToCompleteBusinessCombination
1 pure
ysac Business Combination Period From Ipo For Mandatory Combination
BusinessCombinationPeriodFromIpoForMandatoryCombination
P15M
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, <em style="font: inherit;"> may </em>exceed the Federal Depository Insurance Coverage of <em style="font: inherit;">$250,000.</em> At <em style="font: inherit;"> June 30, 2021</em>, the Company has <em style="font: inherit;">not</em> experienced losses on these accounts and management believes the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q2 ysac Underwriting Agreement Cash Underwriting Discount Per Unit
UnderwritingAgreementCashUnderwritingDiscountPerUnit
0.20
CY2021Q2 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount
UnderwritingAgreementCashUnderwritingDiscountAggregateAmount
2500000 USD
CY2021Q2 ysac Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
0.35
CY2021Q2 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount Including Underwriter Shares
UnderwritingAgreementCashUnderwritingDiscountAggregateAmountIncludingUnderwriterShares
4759615 USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6533651 USD

Files In Submission

Name View Source Status
0001437749-21-018940-index-headers.html Edgar Link pending
0001437749-21-018940-index.html Edgar Link pending
0001437749-21-018940.txt Edgar Link pending
0001437749-21-018940-xbrl.zip Edgar Link pending
ex_256934.htm Edgar Link pending
ex_256935.htm Edgar Link pending
ex_256936.htm Edgar Link pending
ex_256937.htm Edgar Link pending
ex_256938.htm Edgar Link pending
ex_256939.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ysac-20210630.xsd Edgar Link pending
ysac-20210630_cal.xml Edgar Link unprocessable
ysac-20210630_def.xml Edgar Link unprocessable
ysac-20210630_lab.xml Edgar Link unprocessable
ysac-20210630_pre.xml Edgar Link unprocessable
ysac20210630_10q.htm Edgar Link pending
ysac20210630_10q_htm.xml Edgar Link completed